US Patent Issued to Clifton Life Sciences on March 25 for "Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm" (British, American Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,633, issued on March 25, was assigned to Clifton Life Sciences LLC (Charlestown, Saint Kitts and Nevis).

"Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm" was invented by Irvin Mark Modlin (Woodbridge, Conn.), Mark Kidd (New Haven, Conn.) and Ignat Drozdov (Stratford Upon Avon, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods are provided for diagnosing, detecting, or prognosticating a GEP-NEN based on the expression level score of biomarkers exhibiting differential expression in subjects having a GEP-NEN relative to a reference or control sample. The invention also provides compo...